Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model – FirstWord Pharma
Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model FirstWord Pharma Article Source https://firstwordpharma.com/story/5951809
Virtual Machine News Platform
Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model FirstWord Pharma Article Source https://firstwordpharma.com/story/5951809